The United Laboratories International Holdings (HK:3933) has released an update.
The United Laboratories International Holdings Limited has announced an expected net profit of approximately RMB 1.45 billion for the first half of 2024, indicating a significant increase from the RMB 1.28 billion reported in the same period of the previous year. This financial growth is primarily attributed to an increase in gross profit from higher revenue and reduced production costs, alongside savings in selling and distribution expenses, despite higher research and development costs. Shareholders and potential investors are cautioned to be prudent when dealing in the company’s shares.
For further insights into HK:3933 stock, check out TipRanks’ Stock Analysis page.
